Mateusz Korga

Mateusz Korga

Auto-generated profile, based on publicly available information

Mateusz Korga

Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ, Lublin, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2023 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
ATAgata Tokarzewska
Agata Tokarzewska
MKMateusz Korga
Mateusz Korga
AKAdrian Kowalczyk
Adrian Kowalczyk
JMJustyna Małyska
Justyna Małyska
BTBalbina Tybulczuk
Balbina Tybulczuk
Jacek BajJacek Baj
Jacek Baj
The importance of brachial plexus palsy treatment is associated with its significant severity, along with Brachial plexus palsies can be treated by means of many different surgical and non-surgical methods which allow regeneration of full efficiency of the affected limb. The choice of method depends on such factors as type and region of injury, patient’s age or clinical presentation of the injury. The purpose of this review is to present current strategies of treating brachial plexus palsies, depending on therapeutic needs of the particular patient. This is a review study based upon selective literature overview, with emphasis on works published within past 13 years. 6 separate methods of brachial plexus palsy were assessed, without distinction of the reason of palsy occurring. Some of the invasive methods include operative treatment performed directly on occupied nervous tissue, such as microneural plexus reconstruction and nerve transfers (lower subscapular nerve transfer and contralateral C7 nerve transfer) whilst the others revolve around restoration of function of affected neighboring structures by themselves, e.g. shoulder tendon transfers. Rehabilitation and botulinum toxin-based treatment are non-operative methods revolving around enhancement of the function of the affected upper limb. Main measure of effectiveness of the treatment is assessment of the range of motion of the affected limb (ROM). There is still not enough information available regarding long-term efficiency of microneural plexus reconstruction and botulinum toxin-based treatment. They require further investigation while other methods are used commonly.

29 August 2025 in Archiv Euromedica
Verified
Journal Article
Closed access
MKMilena Karolina Krawczyk
Milena Karolina Krawczyk
KZKatarzyna Zych
Katarzyna Zych
DŻDominika Żyła
Dominika Żyła
JNJulia Nowakowska
Julia Nowakowska
PKPiotr Komasara
Piotr Komasara
MKMateusz Korga
Mateusz Korga
Background: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and remains a major cause of cancer-related mortality. Advances in molecular diagnostics have led to new therapeutic approaches based on genetic alterations. Objective: To review recent progress in the treatment of NSCLC, including targeted therapies, immunotherapies, and strategies to overcome drug resistance. Methods: Narrative review based on recent literature. No systematic search strategy was applied. Two summary tables present approved therapies for molecular targets and emerging immune-based strategies. Results: Therapies targeting EGFR, ALK, ROS1, MET, RET, KRAS, and NTRK are discussed, as well as the use of checkpoint inhibitors, CAR-T cells, and bispecific antibodies. Mechanisms of resistance and corresponding therapeutic approaches are reviewed. Some treatment combinations show statistical improvement in progression-free or overall survival, but clinical significance remains to be clarified. Conclusions: Modern NSCLC treatment is increasingly personalized. Molecular profiling guides therapy selection, and novel agents expand options for resistant disease. Further studies should focus on clinical endpoints and optimal treatment combinations.

27 December 2023 in Psychiatria i Psychologia Kliniczna
Verified
Journal Article
Open access
PDF file
JKJakub Klas
Jakub Klas
AGAleksandra Grzywacz
Aleksandra Grzywacz
MKMateusz Korga
Mateusz Korga
NKNatalia Kluz
Natalia Kluz
KKKatarzyna Kulszo
Katarzyna Kulszo
MSMarzena Samardakiewicz
Marzena Samardakiewicz
Introduction: As a result of increased refugee movements over the past few years, it is important to seek systemic solutions to provide medical care to those fleeing to safe countries as soon as possible, especially to pregnant women. To this end, it is necessary to know the existing problems and challenges associated with the care of pregnant refugees, and to find solutions to address them. Methods: A systematic review of the literature from 2016–2023 was conducted according to the PRISMA criteria. Results: Refugee women face a range of problems that need attention, ranging from changes in family dynamics, getting used to a new environment, fear for safety, lack of necessary support, isolation from family members, to overcoming the traumatic experiences left behind in the country of origin. Despite the adoption of assistance strategies in countries hosting refugee women, their implementation has often been far from ideal, even in highly developed countries, which has further negatively affected the mental state of pregnant refugee women in highly stressful situations. Conclusions: Caring for pregnant refugee women goes far beyond maternity care. It is an active process in which the main goals include giving birth to healthy offspring, achieving mental health, stress relief, and social integration of the refugee women themselves, including family relationships. We hope that the lessons learned from the mistakes of previous experiences will help the refugee host countries prepare for situations in which they need to assist pregnant women in crisis, including the provision of psychological support.

8 August 2025 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
KZKatarzyna Zych
Katarzyna Zych
MKMateusz Korga
Mateusz Korga
DŻDominika Żyła
Dominika Żyła
AJAdam Jakubas
Adam Jakubas
AZAndrzej Paweł Zuzak
Andrzej Paweł Zuzak
SKSylwia Koziej
Sylwia Koziej
Introduction and objective: Paediatric-onset multiple sclerosis (POMS) is a chronic, immune-mediated disease of the central nervous system that manifests before the age of 18. Although relatively rare, it poses unique diagnostic and therapeutic challenges due to differences in immune system...

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
BGBartłomiej Grodziński
Bartłomiej Grodziński
DŁDominik Łepecki
Dominik Łepecki
WDWiktoria Natalia Dzierzgowska
Wiktoria Natalia Dzierzgowska
MNMartyna Niemczuk
Martyna Niemczuk
MKMateusz Korga
Mateusz Korga
AKAgata Karasiewicz
Agata Karasiewicz
Chronic Kidney Disease (CKD) is a significant global health issue characterized by progressive loss of kidney function, impacting quality of life and increasing the risk of morbidity and mortality. This paper explores the multifaceted role of physical activity in managing CKD, focusing on its benefits, safety considerations, and best practices for exercise prescription, based on systematic reviews of literature sourced from PubMed and Google Scholar. While physical activity has been shown to offer substantial benefits, such as improved cardiovascular outcomes, enhanced physical function, and reduced inflammation, safety concerns are paramount. These include potential risks associated with exercise intensity and its effects on kidney function and overall health. The paper also evaluates best practices for integrating exercise into CKD management, based on recent evidence and expert recommendations. Our findings suggest that regular physical activity is a crucial component of CKD management, with significant potential to improve patient outcomes. However, tailored exercise programs that account for individual patient conditions and disease stages are essential to maximize benefits and minimize risks. This review underscores the need for ongoing research and refined guidelines to optimize exercise interventions for CKD patients, ensuring safe and effective integration into standard care practices.

12 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
WZWojciech Zezuliński
Wojciech Zezuliński
FWFilip Jan Wolinski
Filip Jan Wolinski
JZJulia Zyśk
Julia Zyśk
MKMateusz Korga
Mateusz Korga
JKJakub Klas
Jakub Klas
EDEliasz Dzierżyński
Eliasz Dzierżyński
Introduction: Ewing sarcoma is the second most common bone tumor among children, and due to its high malignancy 5-year survival rate for patients with primary lesions is around 70%. This number drops to merely 30% if metastases are present. Despite combined modality treatment, including radiotherapy, surgery, pre- and post-surgery chemotherapy, the mortality of patients is still too high. This shows a great need to look for new therapeutic options. Methodology: Comprehensive literature review was conducted across databases, including PubMed and Google Scholar for studies published between 2000 and 2023. This review presents factors that play a key role in pathogenesis and are potential points of targeted therapy. The paper discusses, among other things, treatment attempts based on the role of the EWS-FLI1 protein, epigenetics, tyrosine kinase inhibitors, immunotherapies and the use of nanomedicine and viruses, as well as the difficulties associated with their application. Findings: The studies cited vary depending on the phase of the clinical trial they are on, of which teprotumumab, robatumumab, and a combination of cixutumumab/temsyrolimus, ivodesinib, Nivolumab (a PD-1 inhibitor), and Ipilimumab (a CTLA-4 inhibitor) are quite advanced as well as those conducted only on animals and in vitro like YK-4-279 molecule, mithramycin 2'-oxime, NK cells, siRNAs with cationic detonation nanodiamonds (DNDs) and Il-12 by means of lentiviruses. Conclusions: They are new and promising approaches in cases where standard treatments fail, yet they still require further study. Knowledge of the mechanisms of Ewing's sarcoma formation and its metastases, currently accepted treatment standards, critical points in the pathomechanism and current attempts at treating Ewing's sarcoma is essential for choosing the best treatment and effectively reducing its mortality rate.